Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Chi-Fai Ng"'
Autor:
Hao Zeng, Chi-Fai Ng, Jeremy Yuen-Chun Teoh, Yu Wei, Guangxi Sun, Peter Ka-Fung Chiu, Beihe Wang, Dingwei Ye, Bo Dai, Xiaojian Qin, Jian Pan, Hualei Gan, Guowen Lin, Yao Zhu, Fangning Wan, Cai-Yun He, Junlong Wu, Yuchao Ni, Fangjian Zhou, Yonghong Li
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:54-62
Background: Although China accounts for 7.8% of worldwide new prostate cancer (PCa) cases and 14.5% of new deaths according to GLOBOCAN 2020, the risk of PCa associated with germline mutations is poorly defined, hampered in part by lack of nationwide
Autor:
Tingting Xie, W K Jacky Lam, Wenlei Peng, Suk Hang Cheng, Spencer C. Ding, K.C. Allen Chan, Chi-Fai Ng, Peiyong Jiang, Peter Ka-Fung Chiu, Jeremy Yuen-Chun Teoh, Rossa W.K. Chiu, Ze Zhou, Y.M. Dennis Lo, Timothy H.T. Cheng, Macy M. S. Heung
Publikováno v:
Clinical Chemistry. 67:621-630
BackgroundDouble-stranded DNA in plasma is known to carry single-stranded ends, called jagged ends. Plasma DNA jagged ends are biomarkers for pathophysiologic states such as pregnancy and cancer. It remains unknown whether urinary cell-free DNA (cfDN
Autor:
Ryan Tsz-Hei Tse, Hongda Zhao, Christine Yim-Ping Wong, Angel Wing-Yan Kong, Ronald Cheong-Kin Chan, Ka-Fai To, Chi-Fai Ng, Jeremy Yuen-Chun Teoh
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Scientific Reports
Scientific Reports
Urinary bladder cancer is a common cancer worldwide. Currently, the modality of treating and monitoring bladder cancer is wide. Nonetheless, the high recurrence rate of non-muscle-invasive bladder cancer after surgical resection is still unsatisfacto
Autor:
Chi-Fai Ng, Aqua Asif, Oliver Burton, Shahrokh F. Shariat, Olayinka Gbolahan, Jasmine Sze Ern Koe, Melissa Premchand, G. Giannarini, Nicole Wang, Jeffrey J. Leow, Vinson Wai-Shun Chan, Wilson To, Dmitry Enikeev, Wei Shen Tan, Nikhil Vasdev, Eoin Dinneen, Hassan Kadhim, Jeremy Yuen-Chun Teoh, Alexander Ng
Publikováno v:
Cancers, Vol 13, Iss 3274, p 3274 (2021)
Cancers
Cancers
Simple Summary We reviewed the evidence available for postponing or delaying cancer surgery for localised prostate cancer. Watchful waiting is an acceptable option in low-risk patients. Evidence is uncertain in postponing surgery, but conservative es
Autor:
Byung Ha Chung, Ji Youl Lee, Hideyuki Akaza, Tomotaka Taniguchi, Jasmine Lim, Kai Zhang, Lukman Hakim, Chi-Fai Ng, Choung Soo Kim, Rainy Umbas, Teng Aik Ong, Wun-Jae Kim
Publikováno v:
Japanese Journal of Clinical Oncology. 49:581-586
The Asian Prostate Cancer (A-CaP) Study is an Asia-wide prospective registry study for surveying the treatment outcome of prostate cancer patients who have received a histopathological diagnosis. The study aims to clarify the clinical situation for p
Autor:
Jeremy Yuen-Chun Teoh, Felix Chan, Kelvin K.F. Tsoi, Chi-Fai Ng, Hoyee W. Hirai, Jason M.W. Ho
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 10, p e0221775 (2019)
PLoS ONE, Vol 14, Iss 10, p e0221775 (2019)
To investigate the global incidence of prostate cancer with special attention to the changing age structures. Data regarding the cancer incidence and population statistics were retrieved from the International Agency for Research on Cancer in World H
Autor:
Zhenyu Xu, Kexin Xu, Chi-Fai Ng, Zhu Wang, Wenxing You, Dinglan Wu, Franky L. Chan, Shan Yu, Lijia Xiao, Yuliang Wang, Hao Hu
Publikováno v:
Cancer Research. 78:2205-2218
Targeting of steroidogenic enzymes (e.g., abiraterone acetate targeting CYP17A1) has been developed as a novel therapeutic strategy against metastatic castration-resistant prostate cancer (CRPC). However, resistance to steroidal inhibitors inevitably
Autor:
Jeremy Yuen-Chun Teoh, Kevin S. Chan, Neil Hawkins, Chi-Fai Ng, Robert Heggie, Janet Bouttell, Peter Ka-Fung Chiu
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215279 (2019)
A recent study showed that the Prostate Health Index may avoid unnecessary biopsies in men with prostate specific antigen 4-10ng/ml and normal digital rectal examination in the diagnosis of prostate cancer in Hong Kong. This study aimed to conduct an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::579fb3d0009acb208649957661dabf6d
https://eprints.gla.ac.uk/184423/1/184423.pdf
https://eprints.gla.ac.uk/184423/1/184423.pdf
Autor:
Chi-Fai Ng, Chi-Hang Yee
Publikováno v:
Japanese Journal of Clinical Oncology. 45:1103-1106
In Hong Kong, urological malignancy accounted for 9.55% of all the new cases of cancer in 2012. In the male population, prostate cancer was the third most commonly diagnosed cancer, and the fifth leading cause of cancer death. Age-standardized rate o
Autor:
Kuen Chan, Chi-Ho Leung, Snow Law, Jeremy Yuen-Chun Teoh, Darren M.C. Poon, Kai-Man Lai, Michelle F.T. Chan, Chi-Fai Ng, Eric K. C. Lee, Daisy Lam, Tim Chan, Nicole M. Cheng
Publikováno v:
Clinical genitourinary cancer. 17(1)
Background There is a lack of real-world data regarding the treatment outcomes of chemohormonal therapy versus hormonal therapy alone in Chinese men with metastatic hormone-sensitive prostate cancer. Patients and Methods We conducted a territory-wide